Exposure to Any Adverse Childhood Experience Tied to Later Pain Disorders
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 22, 2023 -- The risk for reporting chronic painful disorders rises with increasing numbers of adverse childhood experiences (ACEs), according to a review published online Dec. 18 in the European Journal of Psychotraumatology.
André Bussières, Ph.D., from McGill University in Montreal, and colleagues conducted a systematic literature review and meta-analysis to examine associations between exposure to ACEs and chronic pain and pain-related disability in adults.
Based on 85 included studies (826,452 adults), the researchers found that the likelihood of reporting chronic pain in adulthood was significantly higher among individuals exposed to a direct ACE (adjusted odds ratio [aOR], 1.45). Both chronic pain (aOR, 1.50) and pain-related disability (aOR, 1.46) during adulthood were significantly more likely among individuals reporting childhood physical abuse. There was a dose-response relationship with the risk for chronic pain in adulthood significantly increasing from one ACE (aOR, 1.29) to four or more ACEs (aOR, 1.95). Study quality was generally good or fair.
"These results are extremely concerning, particularly as over 1 billion children -- half of the global child population -- are exposed to ACEs each year, putting them at increased risk of chronic pain and disability later in life," Bussières said in a statement. "There is an urgent need to develop targeted interventions and support systems to break the cycle of adversity and improve long-term health outcomes for those individuals who have been exposed to childhood trauma."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.